flow semaglutide trial Contrary to popular belief: GLP-1 weight loss medications are NOT all about aesthetic weight loss, they REDUCE risk of cardiovascular death, all cause mortality, and now, progression of kidney disease! Just published FLOW Trial a kidney outcomes

Gao X, Chu Y, Wang W, Li W, Zhang W, Cao J, Fu X, Liu H, Chen D, Fan D, Nie Y

Victoria Vargas: say

For extended storage beyond 6 months, refrigerate at 2-8C

Compared to patients on Contrave, those on the GLP-1 drugs were 9.1 times more likely to have pancreatitis, 4.2 times more likely to have a bowel obstruction and 3.7 times more likely to develop gastroparesis, the study found

Retatrutide and Mounjaro (tirzepatide) both target GLP-1 and GIP receptors, but retatrutide additionally activates glucagon receptors

Key Takeaways The Myers Cocktail is an IV therapy that delivers high-dose vitamins and minerals directly into the bloodstream